<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Punjab, India We have investigated the neuroprotective potential of combination of poly (<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase inhibitor (<z:chebi fb="0" ids="17154">nicotinamide</z:chebi> or 3-aminobenzamide) and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> (<z:chebi fb="9" ids="16796">melatonin</z:chebi>) in middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) induced focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>MCAo of 2 h followed by 22 h reperfusion produced large volume of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e> 211.38 +/- 8.35 mm3), volume of <z:hpo ids='HP_0000969'>edema</z:hpo> (60 +/- 2 mm3) and neurological deficits (4.45 +/- 0.25) </plain></SENT>
<SENT sid="2" pm="."><plain>Combination of <z:chebi fb="0" ids="17154">nicotinamide</z:chebi> (500 mg kg(-1), i.p.) and <z:chebi fb="9" ids="16796">melatonin</z:chebi> (10 mg kg(-1), i.p.) significantly decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume to 48 +/- 2.58 mm3 as compared to their individual drug (<z:chebi fb="0" ids="17154">nicotinamide</z:chebi> 76 +/- 12.49mm3, <z:chebi fb="9" ids="16796">melatonin</z:chebi> 76.17 +/- 1.24 mm3) </plain></SENT>
<SENT sid="3" pm="."><plain>A significant improvement was observed in <z:hpo ids='HP_0000969'>edema</z:hpo> volume and neurological deficits with this combination </plain></SENT>
<SENT sid="4" pm="."><plain>Combination of 3-aminobenzamide (20 mg kg(-1), i.p.) and <z:chebi fb="9" ids="16796">melatonin</z:chebi> (10 mg kg(-1), i.p.) also produced similar reduction in infarction, <z:hpo ids='HP_0000969'>edema</z:hpo> and neurological score </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicate that the combination of poly (<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase inhibitor and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> produce enhanced neuroprotection </plain></SENT>
<SENT sid="6" pm="."><plain>Clinical availability and wide therapeutic margin of <z:chebi fb="0" ids="17154">nicotinamide</z:chebi> and <z:chebi fb="9" ids="16796">melatonin</z:chebi> make them a promising drug combination for clinical evaluation in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
</text></document>